Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?
出版年份 2020 全文链接
标题
Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?
作者
关键词
-
出版物
Current Cardiology Reports
Volume 22, Issue 8, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-06-19
DOI
10.1007/s11886-020-01323-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The clinical utility of apoB versus LDL-C/non-HDL-C
- (2020) Ciaran N. Kohli-Lynch et al. CLINICA CHIMICA ACTA
- Apolipoprotein profiling as a personalized approach to the diagnosis and treatment of dyslipidaemia
- (2019) L Renee Ruhaak et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease
- (2019) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Is There a Need to Revise Goals in the Management of Dyslipidemias?
- (2019) David Sinning et al. Current Cardiology Reports
- Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease: Data from UK Biobank
- (2019) Claire Welsh et al. CIRCULATION
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Association of lowering apolipoprotein B with cardiovascular outcomes across various lipid-lowering therapies: Systematic review and meta-analysis of trials
- (2019) Safi U Khan et al. European Journal of Preventive Cardiology
- Clinical review on triglycerides
- (2019) Ulrich Laufs et al. EUROPEAN HEART JOURNAL
- Apolipoprotein B Particles and Cardiovascular Disease
- (2019) Allan D. Sniderman et al. JAMA Cardiology
- Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM
- (2019) Michel R. Langlois et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines
- (2018) Vasanth Sathiyakumar et al. CIRCULATION
- Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
- (2018) Michel R. Langlois et al. CLINICAL CHEMISTRY
- Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding
- (2018) Allan D. Sniderman et al. JOURNAL OF LIPID RESEARCH
- Targeted On-line SPE-LC-MS/MS Assay for the Quantitation of 12 Apolipoproteins from Human Blood
- (2018) Julia Dittrich et al. PROTEOMICS
- Determinants of Achieved LDL Cholesterol and “Non-HDL” Cholesterol in the Management of Dyslipidemias
- (2018) Chris J. Packard Current Cardiology Reports
- Comparison of Low-density Lipoprotein Cholesterol Assessment by Martin/Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation
- (2018) Seth S. Martin et al. JAMA Cardiology
- Comparability of Lipoprotein Particle Number Concentrations Across ES-DMA, NMR, LC-MS/MS, Immunonephelometry, and VAP: In Search of a Candidate Reference Measurement Procedure for apoB and non-HDL-P Standardization
- (2018) Vincent Delatour et al. CLINICAL CHEMISTRY
- The Spectrum of Type III Hyperlipoproteinemia
- (2018) Allan D. Sniderman et al. Journal of Clinical Lipidology
- Which Lipids Should Be Analyzed for Diagnostic Workup and Follow-up of Patients with Hyperlipidemias?
- (2018) Michel R. Langlois et al. Current Cardiology Reports
- ApoB in clinical care: Pro and Con
- (2018) Allan D. Sniderman et al. ATHEROSCLEROSIS
- Development and Validation of Apolipoprotein AI-Associated Lipoprotein Proteome Panel for the Prediction of Cholesterol Efflux Capacity and Coronary Artery Disease
- (2018) Zhicheng Jin et al. CLINICAL CHEMISTRY
- Evaluation of the Non-HDL Cholesterol to Apolipoprotein B Ratio as a Screening Test for Dysbetalipoproteinemia
- (2018) Christopher S. Boot et al. CLINICAL CHEMISTRY
- The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk
- (2018) Pratik B Sandesara et al. ENDOCRINE REVIEWS
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2018) Scott M. Grundy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
- (2018) Peter Willeit et al. LANCET
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Prognostic value of non-high-density lipoprotein cholesterol for mortality in patients with coronary heart disease: A systematic review and meta-analysis
- (2017) Pengda Liao et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk
- (2017) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Test in Context: Lipoprotein(a)
- (2017) Sotirios Tsimikas JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Very-Low-Density Lipoprotein–Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III
- (2017) Raimund Pechlaner et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Test in Context: Lipid Profile, Fasting Versus Nonfasting
- (2017) Børge G. Nordestgaard JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Fasting Versus Nonfasting and Low-Density Lipoprotein Cholesterol Accuracy
- (2017) Vasanth Sathiyakumar et al. CIRCULATION
- 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
- (2016) Todd J. Anderson et al. CANADIAN JOURNAL OF CARDIOLOGY
- Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia
- (2016) Robert S. Rosenson et al. CARDIOVASCULAR DRUGS AND THERAPY
- Reductions in Atherogenic Lipids and Major Cardiovascular EventsClinical Perspective
- (2016) Kausik K. Ray et al. CIRCULATION
- Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease
- (2016) Børge G. Nordestgaard CIRCULATION RESEARCH
- Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
- (2016) Børge G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents
- (2016) Paul M Ridker et al. EUROPEAN HEART JOURNAL
- Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
- (2016) Michael G. Silverman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology
- (2016) Børge G. Nordestgaard et al. JOURNAL OF LIPID RESEARCH
- Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies
- (2015) Lisandro D. Colantonio et al. CIRCULATION
- Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or PlaceboCLINICAL PERSPECTIVE
- (2015) Samia Mora et al. CIRCULATION
- Automated Multiplex LC-MS/MS Assay for Quantifying Serum Apolipoproteins A-I, B, C-I, C-II, C-III, and E with Qualitative Apolipoprotein E Phenotyping
- (2015) I. van den Broek et al. CLINICAL CHEMISTRY
- Residual dyslipidemia according to low-density lipoprotein cholesterol, non–high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010
- (2015) Nathan D. Wong et al. Journal of Clinical Lipidology
- Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group
- (2014) Michel R. Langlois et al. ATHEROSCLEROSIS
- Relations of Change in Plasma Levels of LDL‐C, Non‐HDL‐C and apoB With Risk Reduction From Statin Therapy: A Meta‐Analysis of Randomized Trials
- (2014) George Thanassoulis et al. Journal of the American Heart Association
- Discordance of Low-Density Lipoprotein (LDL) Cholesterol With Alternative LDL-Related Measures and Future Coronary Events
- (2013) Samia Mora et al. CIRCULATION
- Association of Apolipoprotein B and Nuclear Magnetic Resonance Spectroscopy-Derived LDL Particle Number with Outcomes in 25 Clinical Studies: Assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices
- (2013) T. G. Cole et al. CLINICAL CHEMISTRY
- Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile
- (2013) Seth S. Martin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Non–High-Density Lipoprotein Cholesterol, Guideline Targets, and Population Percentiles for Secondary Prevention in 1.3 Million Adults
- (2013) Mohamed B. Elshazly et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Meta-Analysis of Comparison of Effectiveness of Lowering Apolipoprotein B Versus Low-Density Lipoprotein Cholesterol and Nonhigh-Density Lipoprotein Cholesterol for Cardiovascular Risk Reduction in Randomized Trials
- (2012) Jennifer G. Robinson et al. AMERICAN JOURNAL OF CARDIOLOGY
- Substituting non-HDL cholesterol with LDL as a guide for lipid-lowering therapy increases the number of patients with indication for therapy
- (2012) Luís Masana et al. ATHEROSCLEROSIS
- Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins
- (2012) S. Matthijs Boekholdt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Triglycerides and Cardiovascular Disease
- (2011) Michael Miller et al. CIRCULATION
- A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk
- (2011) Allan D. Sniderman et al.
- Seven Direct Methods for Measuring HDL and LDL Cholesterol Compared with Ultracentrifugation Reference Measurement Procedures
- (2010) W. G. Miller et al. CLINICAL CHEMISTRY
- Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices
- (2009) J. H. Contois et al. CLINICAL CHEMISTRY
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Beyond Low-Density Lipoprotein Cholesterol
- (2009) Benoit J. Arsenault et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
- (2009) Jennifer G. Robinson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: implications for clinical practice
- (2008) Allan D. Sniderman Journal of Clinical Lipidology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started